Clinic invests in Hampshire people’s eyecare
Sight-saving specialist Newmedica has officially opened a multimillion-pound clinic for the people of Hampshire.
Dr Paul Singh and Prof Gus Gazzard on laser as first line therapy
Both the American Academy of Ophthalmology (AAO) and the European Glaucoma Society (EGS) have updated their preferred practice regimens to recognize or recommend SLT as an initial intervention for glaucoma and the NICE UK are now guiding doctors to use SLT before drops.
Researchers pursue personalised pathways for glaucoma care
Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.
Midland Eye performs its first Presserflo Microshunt to treat Glaucoma
Eye clinic, Midland Eye, announces the success of its first sight-saving Preserflo Microshunt glaucoma procedure.
Landmark review of glaucoma treatment and research published by Moorfields-led team
Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.
Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.
Glaucoma UK’s National Eye Health Week campaign highlights the significance of timely information in safeguarding eyesight
Glaucoma UK’s campaign for National Eye Health Week 2023, which will run from 18-24 September, focuses on delivering essential bitesize information about glaucoma that can be read or viewed in under one minute.
Glaucoma UK’s campaign raises awareness of glaucoma through people’s unique glaucoma stories
Glaucoma UK is marking Glaucoma Awareness Week 2023, which will run from 26 June to 2 July 2023.